Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Helen Wedegaertner"'
Autor:
Cierra A. Birch, Helen Wedegaertner, Lennis B. Orduña-Castillo, Monica L. Gonzalez Ramirez, Huaping Qin, JoAnn Trejo
Publikováno v:
Frontiers in Molecular Biosciences, Vol 10 (2023)
Introduction: Dysfunction of the endothelium impairs its’ protective role and promotes inflammation and progression of vascular diseases. Activated Protein C (APC) elicits endothelial cytoprotective responses including barrier stabilization, anti-i
Externí odkaz:
https://doaj.org/article/d9be02a8021e49b38514beaef6fa1af0
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-14 (2019)
Abstract Background The oncoprotein MYC has the dual capacity to drive cell cycle progression or induce apoptosis, depending on the cellular context. BAG1 was previously identified as a transcriptional target of MYC that functions as a critical deter
Externí odkaz:
https://doaj.org/article/6b22ccd228454ba2acf8e16bbd46492c
Publikováno v:
Molecular Biology of the Cell.
The α-arrestin ARRDC3 is a recently discovered tumor suppressor in invasive breast cancer that functions as a multi-faceted adaptor protein to control protein trafficking and cellular signaling. However, the molecular mechanisms which control ARRDC3
Publikováno v:
Antioxidants & redox signaling, vol 36, iss 13-15
Antioxid Redox Signal
Antioxid Redox Signal
SIGNIFICANCE: Adaptor proteins control the spatiotemporal dynamics of cellular signaling. Dysregulation of adaptor protein function can cause aberrant cell signaling and promote cancer. The arrestin family of adaptor proteins are known to regulate si
Autor:
JoAnn Trejo, Helen Wedegaertner
Publikováno v:
The FASEB Journal. 36
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-14 (2019)
BMC Cancer
BMC Cancer
Background The oncoprotein MYC has the dual capacity to drive cell cycle progression or induce apoptosis, depending on the cellular context. BAG1 was previously identified as a transcriptional target of MYC that functions as a critical determinant of
Autor:
Logan Chinn, Wen-An Pan, Helen Wedegaertner, Ivette Roca-Mercado, Taranjit S. Gujral, JoAnn Trejo, Aleena K. S. Arakaki
Publikováno v:
J Cell Sci
Journal of cell science, vol 134, iss 8
Journal of cell science, vol 134, iss 8
The α-arrestin domain containing protein 3 (ARRDC3) is a tumor suppressor in triple-negative breast carcinoma (TNBC), a highly metastatic subtype of breast cancer that lacks targeted therapies. Thus, understanding the mechanisms and targets of ARRDC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40bd8c29d3e44bd907e91f86be3bbdc4
https://europepmc.org/articles/PMC8084569/
https://europepmc.org/articles/PMC8084569/
Publikováno v:
Molecular Cancer Research. 18:A16-A16
G protein-coupled receptors (GPCRs) are key regulators of the Hippo pathway, a well-established mediator of tumorigenesis and cancer progression. The Hippo pathway is a promising therapeutic target, yet developing inhibitors for the core pathway comp
Publikováno v:
The FASEB Journal. 34:1-1
Publikováno v:
The FASEB Journal. 34:1-1